Therapeutic or Drug of Abuse?
Time: 11:30 am
day: Track 1 AM Day 1
Details:
- Over the past decade, there has been an increase in clinical research with psychedelics for treating a number of neuropsychiatric conditions.
- Psilocybin (depression), MDMA (post-traumatic stress disorder) and LSD tartrate (anxiety disorder) along with DMT, 5-MeO-DMT, Ketamine and THC all have (re)newed therapeutic potential & interest.
- Whether your psychedelic drug is designed for a clinically monitored treatment or at-home microdosing, before you can develop a suitable drug treatment – the target compound needs to be characterized.
- Our work focuses on developing analytical tools to evaluate psychedelic compounds and their derivatives.
